Literature DB >> 22421552

Drug treatment court of Vancouver: an empirical evaluation of recidivism.

Julian M Somers1, Lauren Currie, Akm Moniruzzaman, Faith Eiboff, Michelle Patterson.   

Abstract

BACKGROUND: Drug treatment courts (DTCs) have proliferated on the basis of their promise to reduce criminal recidivism among the burgeoning numbers of drug-related offenders. Empirical research on the effectiveness of DTCs indicates that they produce reductions in recidivism, primarily drawn from experiences in the US. There are no published outcome studies on Canadian DTCs. Canada's second DTC has operated in Vancouver's Downtown Eastside since 2001. We examine longitudinal changes in recidivism and characteristics of participants in the DTC in Vancouver (DTCV).
METHODS: DTCV participants (n=180) were included in a longitudinal cohort design (intent-to-treat), and a comparison group was derived using the propensity score matching method. Matching variables represented the domains of health, offending, and socio-economic histories as well as demographics. Annualized rates of offending were compared for the two years prior to entering DTCV and two years following programme termination.
RESULTS: Compared to the matched group of offenders, DTCV participants exhibited significantly greater reductions in offending, and a significant decrease in drug-related offences. The characteristics of DTCV participants differ significantly from those of the larger offender population in the DTES.
CONCLUSION: Results provide empirical support for the DTCV in relation to the goal of reducing criminal recidivism. Participants in the DTCV are disadvantaged in diverse ways apart from their offence-related difficulties. These results have implications for the design of DTC programmes, as well as for future research.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22421552     DOI: 10.1016/j.drugpo.2012.01.011

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  8 in total

1.  The prevalence and geographic distribution of complex co-occurring disorders: a population study.

Authors:  J M Somers; A Moniruzzaman; S N Rezansoff; J Brink; A Russolillo
Journal:  Epidemiol Psychiatr Sci       Date:  2015-05-20       Impact factor: 6.892

2.  Crime-Specific Recidivism in Criminal Justice Clients with Substance Use-A Cohort Study.

Authors:  Anna Karlsson; Anders Håkansson
Journal:  Int J Environ Res Public Health       Date:  2022-06-22       Impact factor: 4.614

3.  Arguments in favour of compulsory treatment of opioid dependence.

Authors:  Zunyou Wu
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

4.  High-frequency use of corrections, health, and social services, and association with mental illness and substance use.

Authors:  Julian M Somers; Stefanie N Rezansoff; Akm Moniruzzaman; Carmen Zabarauckas
Journal:  Emerg Themes Epidemiol       Date:  2015-12-18

5.  The effects of participation level on recidivism: a study of drug treatment courts using propensity score matching.

Authors:  Elizabeth J Gifford; Lindsey M Eldred; Sabrina A McCutchan; Frank A Sloan
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-09-24

6.  A 10-year retrospective analysis of hospital admissions and length of stay among a cohort of homeless adults in Vancouver, Canada.

Authors:  Angela Russolillo; Akm Moniruzzaman; Milad Parpouchi; Lauren B Currie; Julian M Somers
Journal:  BMC Health Serv Res       Date:  2016-02-17       Impact factor: 2.655

7.  Beyond recidivism: changes in health and social service involvement following exposure to drug treatment court.

Authors:  Stefanie N Rezansoff; Akm Moniruzzaman; Elenore Clark; Julian M Somers
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-10-31

8.  Migration to the Downtown Eastside neighbourhood of Vancouver and changes in service use in a cohort of mentally ill homeless adults: a 10-year retrospective study.

Authors:  Julian M Somers; Akm Moniruzzaman; Stefanie N Rezansoff
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.